Document:

EX-10.1

 Exhibit 10.1 

$200,000,000 
 U.S. CONCRETE, INC.

 6.375% Senior Notes due 2024 

Purchase Agreement 

January 4, 2017 
 J.P.
Morgan Securities LLC 
 383 Madison Avenue 
 New York, New York
10179 
 Ladies and Gentlemen: 
 U.S.
Concrete, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to J.P. Morgan Securities LLC (“JPMorgan”) $200,000,000 principal amount of its 6.375% Senior Notes due 2024 (the
“Securities”). The Securities will be issued pursuant to the Indenture dated as of June 7, 2016 (the “Base Indenture”) among the Company, the guarantors party thereto and U.S. Bank National Association, as
trustee (the “Trustee”), as supplemented by a supplemental indenture no. 1, dated as of October 12, 2016 (the “First Supplemental Indenture”), as further supplemented by a supplemental indenture no. 2, to be
dated January 9, 2017 among the Company, the guarantors listed in Schedule 1 hereto (the “Guarantors”) and the Trustee (the “Second Supplemental Indenture” and, together with the Base Indenture and the First
Supplemental Indenture, the “Indenture”), and will be guaranteed on a senior unsecured basis by each of the Guarantors (the “Guarantees”). On June 7, 2016, the Company issued $400,000,000 aggregate principal
amount of its 6.375% Senior Notes due 2024 (the “Existing Securities”) under the Base Indenture. The Securities constitute an offering of Additional Securities (as such term is defined in the Base Indenture) under the Base
Indenture. Except as disclosed in the Time of Sale Information as of the Time of Sale and the Offering Memorandum dated as of the date hereof (each, as defined below), the Securities will have terms identical to those of the Existing Securities and,
together with the Existing Securities, will be treated as a single class of securities for all purposes under the Indenture. This purchase agreement (this “Agreement”) is to confirm the agreement concerning the purchase of the
Securities from the Company by JPMorgan. 
 The Securities will be sold to JPMorgan without being registered under the Securities Act of
1933, as amended (the “Securities Act”), in reliance upon an exemption therefrom. The Company and the Guarantors have prepared a preliminary offering memorandum dated January 9, 2017 (the “Preliminary Offering
Memorandum”) and will prepare an offering memorandum dated the date hereof (the “Offering Memorandum”) setting forth information concerning the Company, the Guarantors and the Securities. Copies of the Preliminary Offering
Memorandum have been, and copies of the Offering Memorandum will be, delivered by the Company to JPMorgan pursuant to the terms of this Agreement. The Company hereby confirms that it has authorized the use of the Preliminary Offering Memorandum, the
other Time of Sale Information and the Offering 

 
Memorandum in connection with the offering and resale of the Securities by JPMorgan in the manner contemplated by this Agreement. Capitalized terms used but not defined herein shall have the
meanings given to such terms in the Preliminary Offering Memorandum. References herein to the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum shall be deemed to refer to and include any document incorporated
by reference therein and any reference to “amend,” “amendment” or “supplement” with respect to the Preliminary Offering Memorandum or the Offering Memorandum shall be deemed to refer to and include any documents filed
after such date and incorporated by reference therein. 
 At or prior to the time when sales of the Securities were first made (the
“Time of Sale”), the Company had prepared the following information (collectively, the “Time of Sale Information”): the Preliminary Offering Memorandum, as supplemented and amended by the written communications
listed on Annex A hereto. 
 The Company intends to use the proceeds of the offering of the Securities for general corporate purposes as
described under “Use of Proceeds” in the Time of Sale Information. 
 Holders of the Securities (including JPMorgan and its direct
and indirect transferees) will be entitled to the benefits of a Registration Rights Agreement, to be dated as of the Closing Date and substantially in the form attached hereto as Exhibit A (the “Registration Rights Agreement”),
pursuant to which the Company and the Guarantors will agree to file one or more registration statements with the Securities and Exchange Commission (the “Commission”) providing for the registration under the Securities Act of the
Securities or the Exchange Securities referred to (and as defined) in the Registration Rights Agreement and the related Guarantees. 
 The
Company and the Guarantors hereby confirm their agreement with JPMorgan concerning the purchase and resale of the Securities, as follows: 

1.    Purchase and Resale of the Securities. 

(a)    The Company agrees to issue and sell the Securities to JPMorgan as provided in this Agreement, and JPMorgan, on the
basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees to purchase from the Company the Securities at a price equal to 104.625% of the principal amount thereof plus accrued
interest from December 1, 2016 to the Closing Date. The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided herein. 

(b)    The Company understands that JPMorgan intends to offer the Securities for resale on the terms set forth in the Time
of Sale Information. JPMorgan represents, warrants and agrees that: 
 (i)    it is a qualified
institutional buyer within the meaning of Rule 144A under the Securities Act (a “QIB”) and an accredited investor within the meaning of Rule 501(a) of Regulation D under the Securities Act (“Regulation D”); 

  
 2 

 (ii)    it has not solicited offers for, or offered or sold,
and will not solicit offers for, or offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning
of Section 4(a)(2) of the Securities Act; and 
 (iii)    it has not solicited offers for, or offered or
sold, and will not solicit offers for, or offer or sell, the Securities as part of their initial offering except: 

(A)    to persons whom it reasonably believes to be QIBs in transactions pursuant to Rule 144A under the Securities Act
(“Rule 144A”) and in connection with each such sale, it has taken or will take reasonable steps to ensure that the purchaser of the Securities is aware that such sale is being made in reliance on Rule 144A; or 

(B)    in accordance with the restrictions set forth in Annex C hereto. 

(c)    JPMorgan acknowledges and agrees that the Company and, for purposes of the “no registration” opinions to
be delivered to JPMorgan pursuant to Sections 6(f) and 6(h) hereof, counsel for the Company and counsel for JPMorgan, respectively, may rely upon the accuracy of the representations and warranties of JPMorgan and compliance by JPMorgan with its
agreements, in each case, contained in paragraph (b) above (including Annex C hereto), and JPMorgan hereby consents to such reliance. 

(d)    The Company acknowledges and agrees that JPMorgan may offer and sell Securities to or through any affiliate of
JPMorgan and that any such affiliate may offer and sell Securities purchased by it to or through JPMorgan. 
 (e)    The
Company and the Guarantors acknowledge and agree that JPMorgan is acting solely in the capacity of an arm’s length contractual counterparty to the Company and the Guarantors with respect to the offering of Securities contemplated hereby
(including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company, the Guarantors or any other person. Additionally, JPMorgan is not advising the Company, the
Guarantors or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Guarantors shall consult with their own advisors concerning such matters and shall be responsible for making
their own independent investigation and appraisal of the transactions contemplated hereby, and JPMorgan shall not have any responsibility or liability to the Company or the Guarantors with respect thereto. Any review by JPMorgan of the Company, the
Guarantors, and the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of JPMorgan and shall not be on behalf of the Company, the Guarantors or any other person. 

  
 3 

 2.    Payment and Delivery. 

(a)    Payment for and delivery of the Securities will be made at the offices of Cravath, Swaine & Moore LLP, 825
Eighth Avenue, New York, New York 10019 at 10:00 A.M., New York City time, on January 9, 2017, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as JPMorgan and the Company may
agree upon in writing. The time and date of such payment and delivery is referred to herein as the “Closing Date”. 

(b)    Payment for the Securities shall be made by wire transfer in immediately available funds to the account(s)
specified by the Company to JPMorgan against delivery to the nominee of The Depository Trust Company (“DTC”), for the account of JPMorgan, of one or more global notes representing the Securities (collectively, the “Global
Note”), with any transfer taxes payable in connection with the sale of the Securities duly paid by the Company. The Global Note will be made available for inspection by JPMorgan not later than 1:00 P.M., New York City time, on the business
day prior to the Closing Date. 
 3.    Representations and Warranties of the Company and the Guarantors. The
Company and the Guarantors jointly and severally represent and warrant to JPMorgan that: 
 (a)    Preliminary
Offering Memorandum, Time of Sale Information and Offering Memorandum. The Preliminary Offering Memorandum, as of its date, did not, the Time of Sale Information, at the Time of Sale,
did not, and at the Closing Date, will not, and the Offering Memorandum, in the form first used by JPMorgan to confirm sales of the Securities and as of the Closing Date, will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the Company and the Guarantors make no representation or warranty with respect to any
statements or omissions made in reliance upon and in conformity with information relating to JPMorgan furnished to the Company in writing by JPMorgan expressly for use in the Preliminary Offering Memorandum, the Time of Sale Information or the
Offering Memorandum, it being understood and agreed that the only such information furnished by JPMorgan consists of the information described as such in Section 7(b) hereof. 

(b)    Additional Written Communications.    The Company and the Guarantors
(including their agents and representatives, other than JPMorgan in its capacity as such) have not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any written communication
that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company and the Guarantors or their agents and representatives (other than a communication referred to in clauses (i) and (ii)
below), an “Issuer Written Communication”) other than (i) the Preliminary Offering Memorandum, (ii) the Offering Memorandum, (iii) the documents listed on Annex A hereto, including a term sheet substantially in the
form of Annex B hereto, which constitute part of the Time of Sale Information, and (iv) any electronic road show or other written communications, in each 

  
 4 

 
case, used in accordance with Section 4(c). Each such Issuer Written Communication, when taken together with the Time of Sale Information at the Time of Sale, did not, and at the Closing Date
will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided that the
Company and the Guarantors make no representation or warranty with respect to any statements or omissions made in each such Issuer Written Communication in reliance upon and in conformity with information relating to JPMorgan furnished to the
Company in writing by JPMorgan expressly for use in any Issuer Written Communication, it being understood and agreed that the only such information furnished by JPMorgan consists of the information described as such in Section 7(b) hereof. 

(c)    Incorporated Documents. The documents incorporated by reference in each of the Time of Sale
Information and the Offering Memorandum, at the respective times they were or hereafter are filed with the Commission, complied or will comply as to form, as the case may be, in all material respects to the requirements of the Exchange Act and the
rules and regulations of the Commission thereunder, and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of
the circumstances under which they were made, not misleading. 
 (d)    Financial Statements. The
financial statements and the related notes thereto included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum present fairly in all material respects the financial position of the Company and its
subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been prepared in conformity with U.S. generally accepted accounting principles
applied on a consistent basis throughout the periods covered thereby; and the other financial information included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum has been derived from the accounting
records of the Company and its subsidiaries and presents fairly in all material respects the information shown thereby. The interactive data in eXtensbile Business Reporting Language included or incorporated by reference in each of the Preliminary
Offering Memorandum, the Time of Sale Information and the Offering Memorandum to the extent set forth in Rule 402(a)(2) of Regulation S-T fairly presents the information called for in all material respects and
is prepared in accordance with the Commission’s rules and guidelines applicable thereto. 
 (e)    No
Material Adverse Change. Since the date of the most recent financial statements of the Company included or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum, except as otherwise
disclosed in each of the Time of Sale Information and the Offering Memorandum, (i) there has not been any material change in the capital stock or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any
kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, in or affecting the business, properties, rights,
assets, management, financial position, results of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) 

  
 5 

 
neither the Company nor any of its subsidiaries has entered into any transaction or agreement that is material to the Company and its subsidiaries taken as a whole or incurred any liability or
obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is material to the
Company and its subsidiaries taken as a whole from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or any action, order or decree of any court or arbitrator or governmental or regulatory
authority. 
 (f)    Organization and Good Standing. The Company and each of its
subsidiaries have been duly organized and are validly existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in which their
respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they
are engaged, except where the failure to be so qualified, in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on the business, properties, rights, assets, management, financial
position, results of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company and the Guarantors of their obligations under this Agreement, the Securities and the Guarantees (“Material
Adverse Effect”). The Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Schedule 2 to this Agreement. 

(g)    Capitalization. The Company has the capitalization as set forth in each of the Time of Sale Information and
the Offering Memorandum under the heading “Capitalization”; and all the outstanding shares of capital stock or other equity interests of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party
(collectively, “Liens”), except for Liens pursuant to the Second Amended and Restated Loan and Security Agreement, dated as of November 18, 2015, among the Company, certain of its subsidiaries party thereto, the lenders party
thereto and Bank of America, N.A., as administrative agent (the “Credit Agreement”). 

(h)    Due Authorization. The Company and each of the Guarantors have the requisite corporate, limited
liability company, or limited partnership, as applicable, right, power and authority to execute and deliver this Agreement, the Securities, the Indenture (including each Guarantee set forth therein), the Exchange Securities (including the related
Guarantees) and the Registration Rights Agreement, in each case, to the extent a party thereto (collectively, the “Transaction Documents”) and to perform their respective obligations hereunder and thereunder; and all action required
to be taken for the due and proper authorization, execution and delivery of each of the Transaction Documents and the consummation of the transactions contemplated thereby has been duly and validly taken. 

  
 6 

 (i)    The Indenture. Each of the Base Indenture and the First
Supplemental Indenture (including the guarantees set forth therein, respectively) has been duly authorized, executed and delivered by the Company and each of the guarantors party thereto and constitutes a valid and legally binding agreement of the
Company and each of the guarantors party thereto enforceable against the Company and each of the guarantors party thereto in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent transfer or conveyance or other similar laws affecting the enforcement of creditors’ rights generally or by equitable principles relating to enforceability (collectively, the “Enforceability Exceptions”);
each of the Base Indenture and the First Supplemental Indenture conforms in all material respects to the requirements of the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”), and the rules and regulations of the
Commission applicable to an indenture that is qualified thereunder; the Second Supplemental Indenture (including the Guarantees set forth therein) has been duly authorized by the Company and each of the Guarantors and on the Closing Date will be
duly executed and delivered by the Company and each of the Guarantors and, when duly executed and delivered in accordance with its terms by each of the parties thereto, will constitute a valid and legally binding agreement of the Company and each of
the Guarantors enforceable against the Company and each of the Guarantors in accordance with its terms, subject to the Enforceability Exceptions; and on the Closing Date, the Indenture will conform in all material respects to the requirements of the
Trust Indenture Act and the rules and regulations of the Commission applicable to an indenture that is qualified thereunder. 

(j)    The Securities and the Guarantees. The Securities have been duly authorized by
the Company and, when duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding and will constitute valid and legally binding obligations of the
Company enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture; and the Guarantees have been duly authorized by each of the Guarantors and, when
the Securities have been duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be valid and legally binding obligations of each of the Guarantors, enforceable against each of the
Guarantors in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. 

(k)    The Exchange Securities. On the Closing Date, the Exchange Securities (including the related
Guarantees) will have been duly authorized by the Company and each of the Guarantors and, when duly executed, authenticated, issued and delivered in connection with the exchange offer as contemplated by the Registration Rights Agreement, will be
duly and validly issued and outstanding and will constitute valid and legally binding obligations of the Company, as issuer of such Exchange Securities, and each of the Guarantors, as guarantor of such Exchange Securities, enforceable against the
Company and each of the Guarantors in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. 

  
 7 

 (l)    Purchase and Registration Rights
Agreements. This Agreement has been duly authorized, executed and delivered by the Company and each of the Guarantors; and the Registration Rights Agreement has been duly authorized by the Company and each of the Guarantors and on the Closing
Date will be duly executed and delivered by the Company and each of the Guarantors and, when duly executed and delivered in accordance with its terms by each of the parties thereto, will constitute a valid and legally binding agreement of the
Company and each of the Guarantors enforceable against the Company and each of the Guarantors in accordance with its terms, subject to the Enforceability Exceptions, and except that rights to indemnity and contribution thereunder may be limited by
applicable law and public policy. 
 (m)    Descriptions of the Transaction
Documents. Each Transaction Document conforms in all material respects to the description thereof contained in each of the Time of Sale Information and the Offering Memorandum. 

(n)    No Violation or Default. Neither the Company nor any of its subsidiaries is (i) in
violation of its charter or by-laws or similar organizational documents; (ii) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due
performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or
any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries is subject; or (iii) in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or
governmental or regulatory authority, except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate, have a Material Adverse Effect. 

(o)    No Conflicts. The execution, delivery and performance by the Company and each of the Guarantors of
each of the Transaction Documents to which each is a party, the issuance and sale of the Securities and the issuance of the related Guarantees, the issuance of the Exchange Securities and the related Guarantees and the consummation of the
transactions contemplated by the Transaction Documents will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, result in the termination, modification or acceleration
of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries is subject, (ii) result in any
violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its subsidiaries or (iii) result in the violation of any law or statute or any judgment,
order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, termination, modification, acceleration, lien,
charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect. 

  
 8 

 (p)    No Consents Required. No consent, approval,
authorization, order, registration or qualification of or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company and each of the Guarantors of each of the
Transaction Documents to which each is a party, the issuance and sale of the Securities and issuance of the related Guarantees, the issuance of the Exchange Securities and the related Guarantees and the consummation of the transactions contemplated
by the Transaction Documents, except for such consents, approvals, authorizations, orders, registrations or qualifications as may be required (i) under applicable state securities laws in connection with the purchase and resale of the
Securities by JPMorgan and (ii) with respect to the Exchange Securities (including the related Guarantees) and the Indenture, under the Securities Act, the Trust Indenture Act and applicable state securities laws as contemplated by the
Registration Rights Agreement. 
 (q)    Legal Proceedings. Except as described in each of the Time of
Sale Information and the Offering Memorandum, there are no legal, governmental or regulatory investigations, actions, suits, or proceedings (“Actions”) pending to which the Company or any of its subsidiaries is a party or to which
any property, right or asset of the Company or any of its subsidiaries is subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, could reasonably be expected to have a Material Adverse
Effect; and no such Actions are, to the knowledge of the Company and each of the Guarantors, threatened or contemplated by any governmental or regulatory authority or by others. 

(r)    Independent Accountants. Grant Thornton LLP, who have certified certain financial statements of the
Company and its subsidiaries, is an independent public accountant with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United
States) and as required by the Securities Act. 
 (s)    Real and Personal Property. The
Company and its subsidiaries have good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its subsidiaries,
in each case, free and clear of all Liens and defects and imperfections of title, except, in the case of any real property subject to a mortgage that secures the Credit Agreement or Liens permitted by the Credit Agreement, and in the case of
personal property, Liens that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries, (ii) could not reasonably be expected, individually or in the aggregate, to have
a Material Adverse Effect or (iii) secure the Credit Agreement. 
 (t)    Intellectual Property.
(i) The Company and its subsidiaries own or have the right to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, domain names, copyrights and copyrightable works
(collectively, “Intellectual Property”) material to the conduct of their respective businesses as currently conducted; (ii) to the knowledge of the Company and any Guarantor, the Company and its subsidiaries’ conduct of
their respective businesses does not infringe, misappropriate or otherwise violate any Intellectual Property of any 

  
 9 

 
person; (iii) the Company and its subsidiaries have not received any written notice of any claim of infringement relating to the Company or any of its subsidiary’s use of any
Intellectual Property; and (iv) to the knowledge of the Company and any Guarantor, the Intellectual Property of the Company and their subsidiaries is not being infringed, misappropriated or otherwise violated by any person. 

(u)    No Undisclosed Relationships. No relationship, direct or indirect, exists between or among the
Company or any of its subsidiaries, on the one hand, and the directors, officers, 5% or greater stockholders or other affiliates of the Company or any of its subsidiaries, on the other, that would be required by the Securities Act to be described in
a registration statement on Form S-1 to be filed with the Commission and that is not so described in or incorporated by reference in each of the Time of Sale Information and the Offering Memorandum. 

(v)    Investment Company Act. Neither the Company nor any of the Guarantors is, and after giving
effect to the offering and sale of the Securities and the application of the proceeds thereof as described in each of the Time of Sale Information and the Offering Memorandum, none of them will be, an “investment company” or an entity
“controlled” by an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Investment Company
Act”). 
 (w)    Taxes. The Company and its subsidiaries have paid all material U.S. federal, state,
local and foreign taxes and filed all material income tax returns required to be paid or filed through the date hereof (taking into account any applicable extensions); and except as otherwise disclosed in each of the Time of Sale Information and the
Offering Memorandum, there is no material income tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets, except for any taxes the
amount or validity of which is currently being contested in good faith or for which adequate reserves have been provided in accordance with U.S. generally accepted accounting principles. 

(x)    Licenses and Permits. The Company and its subsidiaries possess all certificates,
authorizations and permits issued by the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the conduct of their respective businesses in the manner contemplated by the Time of Sale Information
and the Offering Memorandum, except where the failure to possess such certificates, authorizations or permits would not, individually or in the aggregate, have a Material Adverse Effect; and except as described in each of the Time of Sale
Information and the Offering Memorandum, neither the Company nor any of its subsidiaries has received notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, individually or in the
aggregate, if the subject of an unfavorable decision, ruling or finding, could be reasonably expected to have a Material Adverse Effect, and the Company does not reasonably expect any future inability to acquire such certificates, authorizations and
permits as are necessary to conduct its business in the manner contemplated by each of the Time of Sale Information and the Offering Memorandum, except as would not have a Material Adverse Effect. 

  
 10 

 (y)    No Labor Disputes. No labor disturbance by, or
dispute with, employees of the Company or any of its subsidiaries exists or, to the knowledge of the Company and each of the Guarantors, is contemplated or threatened, except as would not have a Material Adverse Effect. Neither the Company nor any
Guarantor is aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of the Company’s or any of the Company’s subsidiaries’ principal suppliers, contractors or customers, except as would not have
a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any written notice of cancellation or termination with respect to any collective bargaining agreement to which it is a party, except as would not have a Material
Adverse Effect. 
 (z)    Compliance with Environmental Laws. Except as described in each of
the Time of Sale Information and the Offering Memorandum, (i) the Company and its subsidiaries (x) are, and at all prior times (except for such matters that have been fully and finally resolved) were, in compliance with any and all
applicable federal, state, local and foreign laws, rules, regulations, requirements, binding decisions and orders relating to hazardous or toxic substances or wastes, pollutants or contaminants, the protection of human health or safety, the
environment and natural resources (collectively, “Environmental Laws”), (y) have received and are in compliance with all permits, licenses, certificates or other authorizations or approvals required of them under applicable
Environmental Laws to conduct their respective businesses, and (z) have not received written notice of any actual or potential liability under or relating to any Environmental Laws, including for the investigation or remediation of any disposal
or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice, and (ii) there are no costs or liabilities
associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and (ii) above, for any such failure to comply, or failure to receive required permits, licenses, certificates,
authorizations, or approvals, or cost or liability, as would not, individually or in the aggregate, have a Material Adverse Effect; and (iii) (x) there are no proceedings that are pending, or that are known to be contemplated, against the
Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceedings regarding which it is reasonably believed no monetary sanctions of $100,000 or more will be imposed,
(y) compliance of the Company and its subsidiaries with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants could not reasonably be
expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z) none of the Company and its subsidiaries anticipates material capital expenditures relating to
compliance with any Environmental Laws. 
 (aa)    Compliance with ERISA. (i) Each employee
benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), for which the Company or any member of its “Controlled Group” (defined as any organization
which is a member of a controlled group of corporations within the meaning of Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended (the “Code”)) would have any liability (each, a
“Plan”) has been maintained in compliance with its terms and the requirements of any applicable statutes, 

  
 11 

 
orders, rules and regulations, including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the
Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of
ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable to such Plan; (iv) no
Plan is, or is reasonably expected to be, in “at risk status” (within the meaning of Section 303(i) of ERISA) or “endangered status” or “critical status” (within the meaning of Section 305 of ERISA); (v) the fair
market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund such Plan); (vi) no “reportable event” (within the meaning of Section 4043(c) of
ERISA) has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and nothing has occurred, whether by action or by failure to act, which would cause the
loss of such qualification and (viii) neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the
Pension Benefit Guarantee Corporation, in the ordinary course and without default) in respect of a Plan (including a “multiemployer plan”, within the meaning of Section 4001(a)(3) of ERISA), except, in each case, with respect to the events
or conditions set forth in (i) through (viii) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect, or as disclosed in the Time of Sale Information or the Offering Memorandum. 

(bb)    Disclosure Controls. The Company and its subsidiaries maintain an effective system of
“disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in reports that it files or
submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such information is accumulated and
communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as
required by Rule 13a-15 of the Exchange Act. 
 (cc)    Accounting
Controls. The Company and its subsidiaries maintain systems of “internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply with the requirements
of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company and its subsidiaries, on a consolidated basis, maintain internal accounting controls
sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with U.S. generally accepted accounting principles and to maintain asset accountability; (iii) access to assets is permitted only in accordance with 

  
 12 

 
management’s general or specific authorization; (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences; and (v) interactive data in eXtensbile Business Reporting Language included or incorporated by reference in each of the Preliminary Offering Memorandum, the Time of Sale Information and the Offering Memorandum
to the extent set forth in Rule 402(a)(2) of Regulation S-T is prepared in accordance with the Commission’s rules and guidelines applicable thereto. Except as disclosed in each of the Time of Sale
Information and the Offering Memorandum, there were no material weaknesses in the Company’s internal controls as of December 31, 2015. 

(dd)    Insurance. The Company and its subsidiaries, on a consolidated basis, have insurance covering such losses
and risks and in such amounts as the Company reasonably believes are adequate for the conduct of their business. Neither the Company nor any of its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital
improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to
obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. 

(ee)    No Unlawful Payments. Neither the Company nor any of its subsidiaries nor any director or
officer of the Company or any of its subsidiaries nor, to the knowledge of the Company and each of the Guarantors, any agent, affiliate, employee or other person, in each case, associated with or acting on behalf of the Company or any of its
subsidiaries, has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of
any direct or indirect unlawful payment or unlawful benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an
official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended,
or any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other
applicable anti-bribery or anti-corruption laws; or (iv) made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment,
kickback or other unlawful payment or unlawful benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce, policies and procedures designed to promote and ensure compliance with all
applicable anti-bribery and anti-corruption laws. 
 (ff)    Compliance with Anti-Money
Laundering Laws. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements, including those of
the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable anti-money laundering statutes of all jurisdictions where the 

  
 13 

 
Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any
governmental agency (collectively, the “Anti-Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its
subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company or any of the Guarantors, threatened. 

(gg)    No Conflicts with Sanctions Laws. Neither the Company nor any of its
subsidiaries, nor any director or officer of the Company or any of its subsidiaries, nor, to the knowledge of the Company or any of the Guarantors, any agent, affiliate, employee or other person, in each case, acting on behalf of the Company or any
of its subsidiaries, is currently the subject or, to the knowledge of the Company, the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S.
Department of the Treasury (“OFAC”) or the U.S. Department of State and including, without limitation, the designation as a “specially designated national” or “blocked person”), the United Nations Security
Council (“UNSC”), the European Union, Her Majesty’s Treasury (“HMT”), or other relevant sanctions authority (collectively, the “Sanctions”), nor is the Company or any of its subsidiaries
located, organized or resident in a country or territory that is the subject or the target of Sanctions (each, a “Sanctioned Country”); and the Company will not, directly or indirectly use the proceeds of the offering of the
Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of
such funding or facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country that, at the time of such funding or facilitation, are the subject or the target of
Sanctions or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as initial purchaser, investor, advisor or otherwise) of Sanctions; provided that, in
the case of clauses (i) and (ii) above, the Company will not enter into any agreement to fund or facilitate any activities of or business (x) with any person that is the subject or the target of Sanctions or (y) in any Sanctioned
Country, in each case, at the time such agreement is signed. For the past 5 years, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with
any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country. 

(hh)    Solvency. On and immediately after the Closing Date, the Company and each Guarantor (after giving effect to
the issuance and sale of the Securities and the issuance of the related Guarantees and the other transactions related thereto as described in each of the Time of Sale Information and the Offering Memorandum) will be Solvent. As used in this
paragraph, the term “Solvent” means, with respect to a particular date and entity, that on such date (i) the present fair market value (and present fair saleable value) of the assets of such entity is not less than the total
amount required to pay the liabilities of such entity on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured; (ii) such entity is able to realize upon its assets and pay its debts and
other liabilities, contingent obligations and commitments as they mature 

  
 14 

 
and become due in the normal course of business; (iii) assuming consummation of the issuance and sale of the Securities and the issuance of the related Guarantees as contemplated by this
Agreement, the Time of Sale Information and the Offering Memorandum, such entity does not have, intend to incur or believe that it will incur debts or liabilities beyond its ability to pay as such debts and liabilities mature; (iv) such entity
is not engaged in any business or transaction, and does not propose to engage in any business or transaction, for which its property would constitute unreasonably small capital after giving due consideration to the prevailing practice in the
industry in which such entity is engaged; and (v) such entity is not a defendant in any civil action that would be reasonably likely to result in a judgment that such entity is or would become unable to satisfy. 

(ii)    No Restrictions on Subsidiaries. No subsidiary of the Company is currently prohibited,
directly or indirectly, under any agreement or other instrument to which it is a party or is subject from paying any dividends to the Company, from making any other distribution on such subsidiary’s capital stock or similar ownership interest,
from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary’s properties or assets to the Company or any other subsidiary of the Company, except for any such restrictions
(a) contained in the Credit Agreement or (b) that will be permitted by the Indenture. 
 (jj)    No
Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against any of them or
JPMorgan for a brokerage commission, finder’s fee or like payment in connection with the offering and sale of the Securities that has not been previously disclosed to JPMorgan. 

(kk)    Rule 144A Eligibility. On the Closing Date, the Securities will not be of the same class as
securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in an automated inter-dealer quotation system; and each of the Preliminary Offering Memorandum and the Offering Memorandum, as of its
respective date, contains or will contain all the information that, if requested by a prospective purchaser of the Securities, would be required to be provided to such prospective purchaser pursuant to Rule 144A(d)(4) under the Securities Act. 

(ll)    No Integration. Neither the Company nor any of its affiliates (as defined in Rule 501(b) of
Regulation D) has, directly or through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Securities
as contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum in a manner that would require registration of the Securities under the Securities Act. 

(mm)    No General Solicitation or Directed Selling Efforts. None of the
Company or any of its affiliates or any other person acting on its or their behalf (other than JPMorgan, as to which no representation is made) has (i) solicited offers for, or offered or sold, the Securities by means of any form of general
solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner 

  
 15 

 
involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engaged in any directed selling efforts within the meaning of Regulation S under the
Securities Act (“Regulation S”), and all such persons have complied with the offering restrictions requirement of Regulation S. 

(nn)    Securities Law Exemptions. Assuming the accuracy of the representations and warranties of
JPMorgan contained in Section 1(b) (including Annex C hereto) and its compliance with its agreements set forth therein, it is not necessary, in connection with the issuance and sale of the Securities to JPMorgan and the offer, resale and delivery of
the Securities by JPMorgan in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum, to register the Securities under the Securities Act or to qualify the Indenture under the Trust Indenture Act. 

(oo)    No Stabilization. Neither the Company nor any of the Guarantors has taken, directly or indirectly,
any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. 

(pp)    Margin Rules. Neither the issuance, sale and delivery of the Securities nor the application of the
proceeds thereof by the Company as described in each of the Time of Sale Information and the Offering Memorandum will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of
Governors. 
 (qq)    Forward-Looking Statements. No forward-looking statement (within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange Act) included or incorporated by reference in any of the Time of Sale Information or the Offering Memorandum has been made or reaffirmed without a reasonable basis or has been
disclosed other than in good faith. 
 (rr)    Industry Statistical and Market Data.
Nothing has come to the attention of the Company or any Guarantor that has caused the Company or such Guarantor to believe that the industry statistical and market-related data included or incorporated by reference in each of the Time of Sale
Information and the Offering Memorandum is not based on or derived from sources that are reliable and accurate in all material respects. 

(ss)    Sarbanes-Oxley Act. There is and has been no failure on the part of the Company or, to the
Company’s knowledge, any of the Company’s directors or officers, in their capacities as such, to comply, in all material respects, with any provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated
in connection therewith (the “Sarbanes-Oxley Act”), including Section 402 related to loans and Sections 302 and 906 related to certifications. 

4.    Further Agreements of the Company and the Guarantors. The Company and the Guarantors jointly and severally
covenant and agree with JPMorgan that: 
 (a)    Delivery of Copies. The Company will deliver,
without charge, to JPMorgan as many copies of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including all amendments and supplements thereto) as JPMorgan may
reasonably request. 

  
 16 

 (b)    Offering Memorandum, Amendments or
Supplements. Before finalizing the Offering Memorandum or making or distributing any amendment or supplement to any of the Time of Sale Information or the Offering Memorandum or filing with the Commission any document that will be
incorporated by reference therein, the Company will furnish to JPMorgan and counsel for JPMorgan a copy of the proposed Offering Memorandum or such amendment or supplement or document to be incorporated by reference therein for review, and will not
distribute any such proposed Offering Memorandum, amendment or supplement or file any such document with the Commission to which JPMorgan reasonably objects. 

(c)    Additional Written Communications. Before making, preparing, using, authorizing, approving or
referring to any Issuer Written Communication, the Company and the Guarantors will furnish to JPMorgan and counsel for JPMorgan a copy of such written communication for review and will not make, prepare, use, authorize, approve or refer to any such
written communication to which JPMorgan reasonably objects. 
 (d)    Notice to JPMorgan. The
Company will advise JPMorgan promptly, and confirm such advice in writing, (i) of the issuance by any governmental or regulatory authority of any order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written
Communication or the Offering Memorandum or the initiation or threatening of any proceeding for that purpose; (ii) of the occurrence of any event at any time prior to the completion of the initial offering of the Securities as a result of which
any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum, in each case, as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing when such Time of Sale Information, Issuer Written Communication or the Offering Memorandum is delivered to a purchaser, not misleading; and (iii) of the receipt by the
Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its commercially
reasonable efforts to prevent the issuance of any such order preventing or suspending the use of any of the Time of Sale Information, any Issuer Written Communication or the Offering Memorandum or suspending any such qualification of the Securities
and, if any such order is issued, will obtain as soon as possible the withdrawal thereof. 
 (e)    Time
of Sale Information. If at any time prior to the Closing Date (i) any event shall occur or condition shall exist as a result of which any of the Time of Sale Information as then amended or supplemented would include any
untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (ii) it is necessary to amend or
supplement the Time of Sale Information to comply with law, the Company will immediately notify JPMorgan thereof and forthwith prepare and, subject to paragraph (b) above, furnish to JPMorgan such amendments or supplements to the Time of Sale
Information (or any document to be filed with the Commission and 

  
 17 

 
incorporated by reference therein) as may be necessary so that the statements in any of the Time of Sale Information as so amended or supplemented (including such documents to be incorporated by
reference therein) will not, in the light of the circumstances under which they were made, be misleading or so that any of the Time of Sale Information will comply with law. 

(f)    Ongoing Compliance of the Offering Memorandum. If at any time prior to
the completion of the initial offering of the Securities (i) any event shall occur or condition shall exist as a result of which the Offering Memorandum as then amended or supplemented would include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser, not misleading or (ii) it is necessary to amend or
supplement the Offering Memorandum to comply with law, the Company will immediately notify JPMorgan thereof and forthwith prepare and, subject to paragraph (b) above, furnish to JPMorgan such amendments or supplements to the Offering Memorandum
(or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Offering Memorandum as so amended or supplemented (including such document to be incorporated by reference
therein) will not, in the light of the circumstances existing when the Offering Memorandum is delivered to a purchaser, be misleading or so that the Offering Memorandum will comply with law. 

(g)    Blue Sky Compliance. The Company will qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as JPMorgan shall reasonably request and will continue such qualifications in effect so long as required for the offering and resale of the Securities; provided that neither the Company nor
any of the Guarantors shall be required to (i) qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to
service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject. 

(h)    Clear Market. During the period from the date hereof through and including the date that is 90 days
after the date hereof, the Company and each of the Guarantors will not, without the prior written consent of JPMorgan, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company or any of the
Guarantors and having a tenor of more than one year. 
 (i)    Use of Proceeds. The Company will
apply the net proceeds from the sale of the Securities as described in each of the Time of Sale Information and the Offering Memorandum under the heading “Use of proceeds”. 

(j)    Supplying Information. While the Securities remain outstanding and are “restricted
securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Company and each of the Guarantors will, during any period in which the Company is not subject to, and in compliance with, Section 13 or 15(d) of the Exchange
Act, furnish to holders of the Securities and prospective purchasers of the Securities designated by such holders, upon the request of such holders or such prospective purchasers, the information required to be delivered pursuant to Rule 144A(d)(4)
under the Securities Act. 

  
 18 

 (k)    DTC. The Company will reasonably assist JPMorgan in arranging
for the Securities to be eligible for clearance and settlement through DTC. 
 (l)    No Resales by
the Company. Until consummation of the exchange offer as contemplated by the Registration Rights Agreement, the Company will not, and will not permit any of its affiliates (as defined in Rule 144 under the Securities Act) to, resell
any of the Securities that have been acquired by any of them, except for Securities purchased by the Company or any of its affiliates and resold in a transaction registered under the Securities Act. 

(m)    No Integration. Neither the Company nor any of its affiliates (as defined in Rule 501(b) of
Regulation D) will, directly or through any agent, sell, offer for sale, solicit offers to buy or otherwise negotiate in respect of, any security (as defined in the Securities Act), that is or will be integrated with the sale of the Securities as
contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum in a manner that would require registration of the Securities under the Securities Act. 

(n)    No General Solicitation or Directed Selling Efforts. None of the
Company or any of its affiliates or any other person acting on its or their behalf (other than JPMorgan, as to which no covenant is given) will (i) solicit offers for, or offer or sell, the Securities by means of any form of general
solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act or (ii) engage in any directed selling efforts within
the meaning of Regulation S, and all such persons will comply with the offering restrictions requirement of Regulation S. 

(o)    No Stabilization. Neither the Company nor any of the Guarantors will take, directly or indirectly,
any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. 

5.    Certain Agreements of JPMorgan. JPMorgan hereby represents and agrees that it has not and will not use,
authorize use of, refer to, or participate in the planning for use of, any written communication that constitutes an offer to sell or the solicitation of an offer to buy the Securities other than (i) the Preliminary Offering Memorandum and the
Offering Memorandum, (ii) any written communication that contains either (a) no “issuer information” (as defined in Rule 433(h)(2) under the Securities Act) or (b) “issuer information” that was included (including
through incorporation by reference) in the Time of Sale Information or the Offering Memorandum, (iii) any written communication listed on Annex A or prepared in accordance with Section 4(c) above (including any electronic road show), (iv) any
written communication prepared by JPMorgan and approved by the Company in advance in writing or (v) any written communication relating to or that contains the terms of the Securities and/or other information that was included (including through
incorporation by reference) in the Time of Sale Information or the Offering Memorandum. 

  
 19 

 6.    Conditions of JPMorgan’s Obligations. The
obligation of JPMorgan to purchase Securities on the Closing Date as provided herein is subject to the performance by the Company and each of the Guarantors of their respective covenants and other obligations hereunder and to the following
additional conditions: 
 (a)    Representations and Warranties. The representations and warranties
of the Company and the Guarantors contained herein shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Company, the Guarantors and their respective officers made in any certificates delivered
pursuant to this Agreement shall be true and correct on and as of the Closing Date. 
 (b)    No
Downgrade. Subsequent to the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement, (i) no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or
preferred stock issued or guaranteed by the Company or any of its subsidiaries by any “nationally recognized statistical rating organization”, as such term is defined under Section 3(a)(62) under the Exchange Act and (ii) no such
organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any other debt securities or preferred stock issued or guaranteed by the Company or
any of its subsidiaries (other than an announcement with positive implications of a possible upgrading or an “under criteria observation” identifier assigned in accordance with Standard & Poor’s Ratings Services’
announcement dated November 13, 2013 of its intention to publish revised criteria for determining certain issuer credit ratings). 

(c)    No Material Adverse Change. No event or condition of a type described in Section 3(e)
hereof shall have occurred or shall exist, which event or condition is not described in each of the Time of Sale Information (excluding any amendment or supplement thereto) and the Offering Memorandum (excluding any amendment or supplement thereto)
the effect of which in the judgment of JPMorgan makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and
the Offering Memorandum. 
 (d)    Officer’s Certificate. JPMorgan shall have received on and as of
the Closing Date a certificate of an executive officer (solely in his or her official capacity) of the Company and of each Guarantor who has specific knowledge of the financial matters of the Company or such Guarantor, as applicable, and is
satisfactory to JPMorgan (i) confirming that such officer has carefully reviewed the Time of Sale Information and the Offering Memorandum and, to the knowledge of such officer, the representations set forth in Sections 3(a) and 3(b) hereof are
true and correct, (ii) confirming that the other representations and warranties of the Company and the Guarantors in this Agreement are true and correct and that the Company and the Guarantors have complied with all agreements and satisfied all
conditions on their part to be performed or satisfied hereunder at or prior to the Closing Date and (iii) to the effect set forth in the immediately preceding paragraphs (b) and (c) above. 

  
 20 

 (e)    Comfort Letters. On the date of this Agreement and on
the Closing Date, Grant Thornton LLP shall have furnished to JPMorgan, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to JPMorgan, in form and substance reasonably satisfactory to JPMorgan,
containing statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference
in each of the Time of Sale Information and the Offering Memorandum; provided that the letters delivered on the Closing Date shall use a “cut-off” date no more than three business days prior
to the Closing Date. 
 (f)    Opinion and 10b-5
Statement of Counsel for the Company. Akin Gump Strauss Hauer & Feld LLP, counsel for the Company, shall have furnished to JPMorgan, at the request of the Company, its written opinion and 10b-5 statement, dated the Closing Date and addressed to JPMorgan, in form and substance reasonably satisfactory to JPMorgan, to the effect set forth in Annex D hereto. 

(g)    Opinions of Local Counsel. (i) Conner & Winters, LLP, counsel for
Atlas-Tuck Concrete, Inc. (the “Oklahoma Guarantor”) in the State of Oklahoma, shall have furnished to JPMorgan, at the request of the Company, its written opinion, dated the Closing Date and addressed to JPMorgan, in form and substance
reasonably satisfactory to JPMorgan, to the effect set forth in Annex E hereto; (ii) Connell Foley LLP, counsel for 160 East 22nd Terminal LLC, Colonial Concrete Co., Eastern Concrete Materials, Inc., Ferrara West LLC, Hamburg Quarry Limited
Liability Company, Master Mix Concrete, LLC, and Premco Organization, Inc. (the “New Jersey Guarantors”) in the State of New Jersey, shall have furnished to JPMorgan, at the request of the Company, its written opinion, dated the Closing
Date and addressed to JPMorgan, in form and substance reasonably satisfactory to JPMorgan, to the effect set forth in Annex F hereto; (iii) Honigman Miller Schwartz and Cohn LLP, counsel for Kurtz Gravel Company (the “Michigan
Guarantor”) in the State of Michigan, shall have furnished to JPMorgan, at the request of the Company, its written opinion, dated the Closing Date and addressed to JPMorgan, in form and substance reasonably satisfactory to JPMorgan, to the
effect set forth in Annex G hereto; and (iv) McKennon Shelton & Henn LLP, counsel for MG, LLC (the “Maryland Guarantor”) in the State of Maryland, shall have furnished to JPMorgan, at the request of the Company, its written
opinion, dated the Closing Date and addressed to JPMorgan, in form and substance reasonably satisfactory to JPMorgan, to the effect set forth in Annex H hereto. 

(h)    Opinion and 10b-5 Statement of
Counsel for JPMorgan. JPMorgan shall have received on and as of the Closing Date an opinion and 10b-5 statement, addressed to JPMorgan, of Cravath, Swaine & Moore LLP, counsel for
JPMorgan, with respect to such matters as JPMorgan may reasonably request, and such counsel shall have received such documents and information as it may reasonably request to enable it to pass upon such matters. 

(i)    No Legal Impediment to Issuance. No action shall have been taken and no statute,
rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities or the issuance of the

  
 21 

 
Guarantees; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities or the
issuance of the Guarantees. 
 (j)    Good Standing. JPMorgan shall have received on and as of the Closing
Date satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization and their good standing in such other jurisdictions as JPMorgan may reasonably request, in each case, in writing or
any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. 

(k)    Registration Rights Agreement. JPMorgan shall have received a counterpart of the Registration
Rights Agreement that shall have been executed and delivered by a duly authorized officer of the Company and each of the Guarantors. 

(l)    DTC. The Securities shall be eligible for clearance and settlement through DTC. 

(m)    Indenture and Securities. The Second Supplemental Indenture shall have been duly executed and
delivered by a duly authorized officer of the Company, each of the Guarantors and the Trustee, and the Securities shall have been duly executed and delivered by a duly authorized officer of the Company and duly authenticated by the Trustee. 

(n)    Additional Documents. On or prior to the Closing Date, the Company and the Guarantors shall have
furnished to JPMorgan such further certificates and documents as JPMorgan may reasonably request. 
 All opinions, letters, certificates and
evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for JPMorgan. 

7.    Indemnification and Contribution. 

(a)    Indemnification of JPMorgan. The Company and each of the Guarantors, jointly and severally,
agree to indemnify and hold harmless JPMorgan, its affiliates, directors and officers and each person, if any, who controls JPMorgan within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against
any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses reasonably incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred),
joint or several, that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Preliminary Offering Memorandum, any of the other Time of Sale Information, any Issuer Written Communication
or the Offering Memorandum or any amendment or supplement thereto or any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading, in each case, except insofar as such losses, claims, damages or liabilities arise out of, or are based 

  
 22 

 
upon, any untrue statement or omission or alleged untrue statement or omission made in the Preliminary Offering Memorandum, any of the other Time of Sale Information, any Issuer Written
Communication or the Offering Memorandum or any amendment or supplement thereto in reliance upon, and in conformity with, any information relating to JPMorgan furnished to the Company in writing by JPMorgan expressly for use therein. 

(b)    Indemnification of the Company and the Guarantors. JPMorgan agrees
to indemnify and hold harmless the Company, each of the Guarantors, each of their respective directors and officers and each person, if any, who controls the Company or any of the Guarantors within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or
omission or alleged untrue statement or omission made in reliance upon, and in conformity with, any information relating to JPMorgan furnished to the Company in writing by JPMorgan expressly for use in the Preliminary Offering Memorandum, any of the
other Time of Sale Information, any Issuer Written Communication or the Offering Memorandum (or any amendment or supplement thereto), it being understood and agreed that the only such information consists of the following information in the
Preliminary Offering Memorandum and the Offering Memorandum: (i) the second and third sentences of the second paragraph, (ii) the third and fourth sentences of the sixteenth paragraph, (iii) the eighteenth paragraph, (iv) the
nineteenth paragraph and (v) the twentieth paragraph, in each case, under the caption “Plan of distribution”. 

(c)    Notice and Procedures. If any suit, action, proceeding (including any governmental or
regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above, such person (the “Indemnified Person”)
shall promptly notify the person against whom such indemnification may be sought (the “Indemnifying Person”) in writing; provided that the failure to notify the Indemnifying Person shall not relieve it from any liability that
it may have under paragraph (a) or (b) above, except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided, further, that the failure to
notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under paragraph (a) or (b) above. If any such proceeding shall be brought or asserted against an Indemnified Person
and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying
Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section 7 that the Indemnifying Person may designate in such proceeding and shall pay the fees and expenses of such proceeding and shall pay
the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such
Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the
Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that 

  
 23 

 
there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including
any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and
agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all
Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred. Any such separate firm for JPMorgan, its affiliates, directors and officers and any control persons of JPMorgan shall be designated in writing by
JPMorgan and any such separate firm for the Company, the Guarantors, their respective directors and officers and any control persons of the Company and the Guarantors shall be designated in writing by the Company. The Indemnifying Person shall not
be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and
against any loss or liability by reason of such settlement or judgment. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any
Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance
reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on
behalf of any Indemnified Person. 
 (d)    Contribution. If the indemnification provided for in paragraph
(a) or (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified
Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the
Company and the Guarantors on the one hand and JPMorgan on the other from the offering of the Securities or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect
not only the relative benefits referred to in clause (i) but also the relative fault of the Company and the Guarantors on the one hand and JPMorgan on the other in connection with the statements or omissions that resulted in such losses,
claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Guarantors on the one hand and JPMorgan on the other shall be deemed to be in the same respective
proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total discounts and commissions received by JPMorgan in connection therewith, as provided in this Agreement, bear to the
aggregate offering price of the Securities. The relative fault of the Company and the Guarantors on the one hand and JPMorgan on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a 

  
 24 

 
material fact relates to information supplied by the Company or any Guarantor or by JPMorgan and the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. 
 (e)    Limitation on Liability. The Company, the Guarantors
and JPMorgan agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the
limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section 7, in no event shall JPMorgan be required to contribute any
amount in excess of the amount by which the total discounts and commissions received by JPMorgan with respect to the offering of the Securities exceeds the amount of any damages that JPMorgan has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation. 
 (f)    Non-Exclusive
Remedies. The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or remedies that may otherwise be available to any Indemnified Person at law or in equity. 

8.    Termination. This Agreement may be terminated in the absolute discretion of JPMorgan, by notice to the
Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date (i) trading generally shall have been suspended or materially limited on the New York Stock Exchange or The NASDAQ Stock Market or the over-the-counter market; (ii) trading of any securities issued or guaranteed by the Company or any of the Guarantors shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there
shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of JPMorgan, is material and adverse and makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Offering Memorandum. 

9.    Payment of Expenses. 

(a)    Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the
Company and each of the Guarantors jointly and severally agree to pay or cause to be paid all costs and expenses incident to the performance of their respective obligations hereunder, including without limitation, (i) the costs incident to the
authorization, issuance, sale, preparation and delivery of the Securities and any stamp, transfer or similar taxes payable in that connection; (ii) the 

  
 25 

 
costs incident to the preparation and printing of the Preliminary Offering Memorandum, any other Time of Sale Information, any Issuer Written Communication and the Offering Memorandum (including
any amendment or supplement thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the fees and expenses of the Company’s and the Guarantors’ counsel and
independent accountants; (v) the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Securities under the laws of such jurisdictions as JPMorgan may designate
and the preparation, printing and distribution of a Blue Sky memorandum (including the related fees and expenses of counsel for JPMorgan); (vi) any fees charged by rating agencies for rating the Securities; (vii) the fees and expenses of
the Trustee and any paying agent (including related fees and expenses of any counsel to such parties); (viii) all expenses and application fees incurred in connection with the approval of the Securities for book-entry transfer by DTC; and
(ix) all expenses incurred by the Company in connection with any “road show” presentation to potential investors. 

(b)    If (i) this Agreement is terminated pursuant to Section 8 hereof, (ii) the Company for any reason
fails to tender the Securities for delivery to JPMorgan or (iii) JPMorgan declines to purchase the Securities for any reason permitted under this Agreement, the Company and each of the Guarantors jointly and severally agree to reimburse
JPMorgan for all out-of-pocket costs and expenses (including the fees and expenses of its counsel) reasonably incurred by JPMorgan in connection with this Agreement and
the offering contemplated hereby. 
 10.    Persons Entitled to Benefit of Agreement. This Agreement shall inure
to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein and the affiliates of JPMorgan referred to in Section 7 hereof. Nothing in
this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Securities from JPMorgan shall be deemed
to be a successor merely by reason of such purchase. 
 11.    Survival. The respective indemnities, rights of
contribution, representations, warranties and agreements of the Company, the Guarantors and JPMorgan contained in this Agreement or made by or on behalf of the Company, the Guarantors or JPMorgan pursuant to this Agreement or any certificate
delivered pursuant hereto shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company, the
Guarantors or JPMorgan. 
 12.    Certain Defined Terms. For purposes of this Agreement, (a) except where
otherwise expressly provided, the term “affiliate” has the meaning set forth in Rule 405 under the Securities Act; (b) the term “business day” means any day other than a day on which banks are permitted or
required to be closed in New York City; (c) the term “subsidiary” has the meaning set forth in Rule 405 under the Securities Act; (d) the term “Exchange Act” means the Securities Exchange Act of 1934, as
amended; and (e) the term “written communication” has the meaning set forth in Rule 405 under the Securities Act. 

  
 26 

 13.    Compliance with USA PATRIOT Act. In accordance with the
requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), JPMorgan is required to obtain, verify and record information that identifies its clients, including
the Company, which information may include the name and address of their respective clients, as well as other information that will allow JPMorgan to properly identify its clients. 

14.    Miscellaneous. 

(a)    Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been
duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to JPMorgan shall be given to J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179 (fax: 212-270-1063); Attention: Geoffrey Benson. Notices to the Company and the Guarantors shall be given to Paul M. Jolas, Vice President, General Counsel & Corporate Secretary, 331 N. Main Street,
Euless, Texas 76039 (fax: 817-835-4165). 

(b)    Governing Law. This Agreement and any claim, controversy or dispute arising under, or related to,
this Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. 

(c)    Submission to Jurisdiction. The Company and each of the Guarantors hereby submit to the
exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit, action or proceeding arising out of, or relating to, this Agreement or the transactions contemplated hereby. The
Company and each of the Guarantors waive any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. Each of the Company and each of the Guarantors agrees that a final judgment in any such
suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and each Guarantor, as applicable, and may be enforced in any court to the jurisdiction of which the Company and each Guarantor, as applicable, is
subject by a suit upon such judgment. 
 (d)    Waiver of Jury Trial. Each of the parties
hereto hereby waives any right to trial by jury in any suit or proceeding arising out of, or relating to, this Agreement. 

(e)    Counterparts. This Agreement may be signed in counterparts (which may include counterparts delivered by any
standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. 

(f)    Amendments or Waivers. No amendment or waiver of any provision of this Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. 

  
 27 

 (g)    Headings. The headings herein are included for convenience of
reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. 

  
 28 

 If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below. 
  

			
	Very truly yours,
	
	U.S. CONCRETE, INC.
		
	By:	 	 /s/ William J. Sandbrook

	Name:	 	William J. Sandbrook
	Title:	 	President and Chief Executive Officer
	
	CUSTOM-CRETE, LLC
	REDI-MIX, LLC
		
	By:	 	 /s/ William J. Sandbrook

	Name:	 	William J. Sandbrook
	Title:	 	Vice President
	
	OUTRIGGER, LLC
		
	By:	 	 /s/ William J. Sandbrook

	Name:	 	William J. Sandbrook
	Title:	 	President

  
 Signature Page to
Purchase Agreement 

 
			
	 HAMBURG QUARRY LIMITED LIABILITY COMPANY

		
	By:	 	 /s/ Kevin R. Kohutek

	Name:	 	Kevin R. Kohutek
	Title:	 	President
	
	 160 EAST 22ND TERMINAL
LLC

	 AGGREGATE & CONCRETE TESTING, LLC

	 COLONIAL CONCRETE CO.

	 EASTERN CONCRETE MATERIALS, INC.

	 FERRARA BROS., LLC

	 FERRARA WEST LLC

	 LOCAL CONCRETE SUPPLY & EQUIPMENT, LLC

	 MASTER MIX CONCRETE, LLC

	 MASTER MIX, LLC

	 MG, LLC

	 NEW YORK SAND & STONE, LLC

	 NYC CONCRETE MATERIALS, LLC

	 PEBBLE LANE ASSOCIATES, LLC

	 PREMCO ORGANIZATION, INC.

	 SUPERIOR CONCRETE MATERIALS, INC.

	 USC ATLANTIC, INC.

	 USC-KINGS, LLC

	VALENTE EQUIPMENT LEASING CORP.
		
	By:	 	 /s/ Kevin R. Kohutek

	Name:	 	Kevin R. Kohutek
	Title:	 	Vice President

  
 Signature Page to
Purchase Agreement 

			
	YARDARM, LLC
		
	By:	 	 /s/ Paul M. Jolas

	Name:	 	Paul M. Jolas
	Title:	 	Secretary

  
 Signature Page to
Purchase Agreement 

 
			
	 ALBERTA INVESTMENTS, INC.

	 ALLIANCE HAULERS, INC.

	 ATLAS REDI-MIX, LLC

	 ATLAS-TUCK CONCRETE, INC.

	 BEALL CONCRETE ENTERPRISES, LLC

	 BEALL INDUSTRIES, INC.

	 BEALL INVESTMENT CORPORATION, INC.

	 BEALL MANAGEMENT, INC.

	 CUSTOM-CRETE REDI-MIX, LLC

	 REDI-MIX CONCRETE, L.P.

	 REDI-MIX GP, LLC

	 RIGHT AWAY REDY MIX INCORPORATED

	 ROCK TRANSPORT, INC.

	 TITAN CONCRETE INDUSTRIES, INC.

	 USC-JENNA, LLC

	 USC PAYROLL, INC.

	 U.S. CONCRETE ON-SITE, INC.

		
	By:	 	 /s/ Ronnie Pruitt

	Name:	 	Ronnie Pruitt
	Title:	 	President

  
 Signature Page to
Purchase Agreement 

 
			
	 AMERICAN CONCRETE PRODUCTS, INC.

	 BODE CONCRETE LLC

	 BODE GRAVEL CO.

	 BRECKENRIDGE READY MIX, INC.

	 CENTRAL CONCRETE SUPPLY CO., INC.

	 CENTRAL PRECAST CONCRETE, INC.

	 INGRAM CONCRETE, LLC

	 KURTZ GRAVEL COMPANY

	 SAN DIEGO PRECAST CONCRETE, INC.

	 SIERRA PRECAST, INC.

	 SMITH PRE-CAST, INC.

	 USC-NYCON, LLC

		
	By:	 	 /s/ Ronnie Pruitt

	Name:	 	Ronnie Pruitt
	Title:	 	Vice President
	
	 CONCRETE XXXIV ACQUISITION, INC.

	 CONCRETE XXXV ACQUISITION, INC.

	 CONCRETE XXXVI ACQUISITION, INC.

	 USC MANAGEMENT CO., LLC

	 USC TECHNOLOGIES, INC.

	 U.S. CONCRETE TEXAS HOLDINGS, INC.

		
	By:	 	 /s/ Ronnie Pruitt

	Name:	 	Ronnie Pruitt
	Title:	 	Treasurer

  
 Signature Page to
Purchase Agreement 

			
	Accepted: January 4, 2017
	
	J.P. MORGAN SECURITIES LLC
		
	By	 	         /s/ Geoff Benson

         Authorized Signatory 

  
 Signature Page to
Purchase Agreement 

 Schedule 1 

Guarantors 
 160 East 22nd Terminal LLC 

Aggregate & Concrete Testing, LLC 
 Alberta Investments,
Inc. 
 Alliance Haulers, Inc. 
 American Concrete Products,
Inc. 
 Atlas Redi-Mix, LLC 

Atlas-Tuck Concrete, Inc. 
 Beall Concrete Enterprises, LLC 

Beall Industries, Inc. 
 Beall Investment Corporation, Inc. 

Beall Management, Inc. 
 Bode Concrete LLC 

Bode Gravel Co. 
 Breckenridge Ready Mix, Inc. 

Central Concrete Supply Co., Inc. 
 Central Precast Concrete, Inc.

 Colonial Concrete Co. 
 Concrete XXXIV Acquisition, Inc. 

Concrete XXXV Acquisition, Inc. 
 Concrete XXXVI Acquisition, Inc.

 Custom-Crete, LLC 
 Custom-Crete Redi-Mix, LLC 
 Eastern Concrete Materials, Inc. 

Ferrara Bros., LLC 
 Ferrara West LLC 

Hamburg Quarry Limited Liability Company 
 Ingram Concrete, LLC

 Kurtz Gravel Company 
 Local Concrete Supply &
Equipment, LLC 
 Master Mix, LLC 
 Master Mix Concrete, LLC

 MG, LLC 
 New York Sand & Stone, LLC 

NYC Concrete Materials, LLC 
 Outrigger, LLC 

Pebble Lane Associates, LLC 
 Premco Organization, Inc. 

Redi-Mix Concrete, L.P. 
 Redi-Mix GP, LLC 
 Redi-Mix, LLC 

Right Away Redy Mix Incorporated 
 Rock Transport, Inc. 

San Diego Precast Concrete, Inc. 
 Sierra Precast, Inc. 

Smith Pre-Cast, Inc. 

Superior Concrete Materials, Inc. 

 Titan Concrete Industries, Inc. 

USC Atlantic, Inc. 

USC-Jenna, LLC 
 USC-Kings, LLC 
 USC Management Co., LLC 

USC-NYCON, LLC 
 USC
Payroll, Inc. 
 USC Technologies, Inc. 
 U.S. Concrete On-Site, Inc. 
 U.S. Concrete Texas Holdings, Inc. 

Valente Equipment Leasing Corp. 
 Yardarm, LLC 

 Schedule 2 

Subsidiaries 
 160 East 22nd Terminal LLC 

Aggregate & Concrete Testing, LLC 
 Alberta Investments,
Inc. 
 Alliance Haulers, Inc. 
 American Concrete Products,
Inc. 
 Atlas Redi-Mix, LLC 

Atlas-Tuck Concrete, Inc. 
 Beall Concrete Enterprises, LLC 

Beall Industries, Inc. 
 Beall Investment Corporation, Inc. 

Beall Management, Inc. 
 Bode Concrete LLC 

Bode Gravel Co. 
 Breckenridge Ready Mix, Inc. 

Central Concrete Supply Co., Inc. 
 Central Precast Concrete, Inc.

 Colonial Concrete Co. 
 Concrete XXXIV Acquisition, Inc. 

Concrete XXXV Acquisition, Inc. 
 Concrete XXXVI Acquisition, Inc.

 Custom-Crete, LLC 
 Custom-Crete Redi-Mix, LLC 
 Eastern Concrete Materials, Inc. 

Ferrara Bros., LLC 
 Ferrara West LLC 

Hamburg Quarry Limited Liability Company 
 Heavy Materials, LLC

 Ingram Concrete, LLC 
 Kurtz Gravel Company 

Local Concrete Supply & Equipment, LLC 
 Master Mix, LLC

 Master Mix Concrete, LLC 
 MG, LLC 

New York Sand & Stone, LLC 
 NYC Concrete Materials, LLC

 Outrigger, LLC 
 Pebble Lane Associates, LLC 

Premco Organization, Inc. 

Redi-Mix Concrete, L.P. 
 Redi-Mix GP, LLC 
 Redi-Mix, LLC 

Right Away Redy Mix Incorporated 
 Rock Transport, Inc. 

San Diego Precast Concrete, Inc. 
 Sierra Precast, Inc. 

Smith Pre-Cast, Inc. 

 Spartan Products, LLC 

Superior Concrete Materials, Inc. 
 Titan Concrete Industries,
Inc. 
 USC Atlantic, Inc. 

USC-Jenna, LLC 
 USC-Kings, LLC 
 USC Management Co., LLC 

USC-NYCON, LLC 
 USC
Payroll, Inc. 
 USC Technologies, Inc. 
 U.S. Concrete On-Site, Inc. 
 U.S. Concrete Texas Holdings, Inc. 

Valente Equipment Leasing Corp. 
 Yardarm, LLC 

 ANNEX A 

Additional Time of Sale Information 

1.    Term sheet containing the terms of the Securities, substantially in the form of Annex B. 

 ANNEX B 

Pricing Term Sheet, dated January 4, 2017 

to Preliminary Offering Memorandum dated January 4, 2017 

Strictly Confidential 

U.S. Concrete, Inc. 
 This
pricing term sheet is made with reference to the Preliminary Offering Memorandum (the “Preliminary Offering Memorandum”). The information in this pricing term sheet supplements the Preliminary Offering Memorandum and updates and
supersedes the information in the Preliminary Offering Memorandum to the extent it is inconsistent with the information in the Preliminary Offering Memorandum. Terms used and not defined herein have the meanings assigned in the Preliminary Offering
Memorandum. 
 On June 7, 2016, the Company issued $400,000,000 aggregate principal amount of its 6.375% Senior Notes due 2024 under an
indenture dated as of June 7, 2016 (the “Base Indenture”) among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by a supplemental
indenture no. 1, dated as of October 12, 2016 (the “First Supplemental Indenture”). The New Notes offered hereby will be issued pursuant to the Base Indenture, as supplemented by the First Supplemental Indenture, and as further
supplemented by a supplemental indenture no. 2 to be dated January 9, 2017 among the Company, the Subsidiary Guarantors and the Trustee (the “Second Supplemental Indenture” and, together with the Base Indenture and the First
Supplemental Indenture, the “Indenture”) and constitute an offering of Additional Securities (as such term is defined in the Base Indenture) under the Indenture. 

The New Notes have not been registered under the Securities Act of 1933, as amended, or the securities laws of any other jurisdiction. The New
Notes may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S) except in transactions exempt from, or not subject to, the registration requirements of the Securities Act. Accordingly, the New Notes are being
offered only (1) to “qualified institutional buyers” as defined in Rule 144A under the Securities Act and (2) outside the United States to non-U.S. persons in compliance with Regulation S
under the Securities Act. 
  

			
	Issuer:	  	U.S. Concrete, Inc.
	Security description:	  	Senior Notes
	Distribution:	  	144A/Reg S registration rights
	Size:	  	$200,000,000
	Gross proceeds:	  	$211,500,000
	Maturity:	  	June 1, 2024
	Coupon:	  	6.375%
	Issue price:	  	105.75% of face amount, plus accrued interest from December 1, 2016.
	Yield to Worst:	  	5.140%
	Spread to Benchmark Treasury:	  	+301bps
	Benchmark Treasury:	  	UST 1.875% due May 31, 2022
	Interest Payment Dates:	  	June 1 and December 1, commencing June 1, 2017

					
	Equity clawback:	  	Up to 35% at 106.375% prior to June 1, 2019
	Optional redemption:	  	
		  	Make-whole call @ T+50bps prior to June 1, 2019 then:

  

							
	 	 	 On or after:
	  	 Price:
	  	 
		 	June 1, 2019	  	104.781%	  	
		 	June 1, 2020	  	103.188%	  	
		 	June 1, 2021	  	101.594%	  	
		 	June 1, 2022 and thereafter	  	100.000%	  	
	Change of control:	 	Putable at 101% of principal plus accrued and unpaid interest
	Trade date:	 	January 4, 2017	  	
	Settlement:	 	T+3; January 9, 2017.	  	
	CUSIP:	 	 144A: CUSIP No. 90333L AQ5

REG S: CUSIP No. U9033E AF5
	  	
	ISIN:	 	 144A: ISIN No. US90333LAQ59

REG S: ISIN No. USU9033EAF52
	  	
	Denominations/Multiple:	 	$2,000 x $1,000	  	
	Ratings*:	 	B2/BB-	  	
	Book-Running Manager and Sole Initial Purchaser:	 	J.P. Morgan Securities LLC

 Use of Proceeds 

Estimated net proceeds to the Issuer from the offering of New Notes will be approximately $208.4 million, after deducting JPMorgan’s discounts and
commissions and estimated offering expenses. 
  
  

This material is confidential and is for your information only and is not intended to be used by anyone other than you. This information does not purport to
be a complete description of the New Notes or the offering. Please refer to the Preliminary Offering Memorandum for a complete description. 
 This
communication is being distributed in the United States solely to Qualified Institutional Buyers, as defined in Rule 144A under the Securities Act of 1933, as amended, and outside the United States solely to
Non-U.S. persons as defined under Regulation S. 
 This communication does not constitute an offer to sell or
the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. 

	*	A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. 

Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was
automatically generated as a result of this communication being sent by Bloomberg or another email system. 

 ANNEX C 

Restrictions on Offers and Sales Outside the United States 

In connection with offers and sales of Securities outside the United States: 

(a)    JPMorgan’s acknowledges that the Securities have not been registered under the Securities Act and may not be
offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in transactions not subject to, the registration requirements of the Securities Act. 

(b)    JPMorgan’s represents, warrants and agrees that: 

(i)    JPMorgan has offered and sold the Securities, and will offer and sell the Securities, (A) as
part of its distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering of the Securities and the Closing Date, in each case, only in accordance with Regulation S under the Securities Act
(“Regulation S”) or Rule 144A or any other available exemption from registration under the Securities Act. 

(ii)    None of JPMorgan or any of its affiliates or any other person acting on its or their behalf has
engaged or will engage in any directed selling efforts with respect to the Securities, and all such persons have complied and will comply with the offering restrictions requirement of Regulation S. 

(iii)    At or prior to the confirmation of sale of any Securities sold in reliance on Regulation S,
JPMorgan will have sent to each distributor, dealer or other person receiving a selling concession, fee or other remuneration that purchases Securities from it during the distribution compliance period a confirmation or notice to substantially the
following effect: 
 “The Securities covered hereby have not been registered under the U.S. Securities Act of 1933, as amended (the
“Securities Act”), and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (i) as part of their distribution at any time or (ii) otherwise until 40 days after the later
of the commencement of the offering of the Securities and the date of original issuance of the Securities, in each case, except in accordance with Regulation S or Rule 144A or any other available exemption from registration under the Securities Act.
Terms used above have the meanings given to them by Regulation S.” 
 (iv)    JPMorgan has not and
will not enter into any contractual arrangement with any distributor with respect to the distribution of the Securities, except with its affiliates or with the prior written consent of the Company. 

Terms used in paragraph (a) and this paragraph (b) and not otherwise defined in this Agreement have the meanings given to them by Regulation S. 

(c)    JPMorgan acknowledges that no action has been or will be taken by the Company that would permit a public offering
of the Securities or possession or distribution of any of the Time of Sale Information, the Offering Memorandum, any Issuer Written Communication or any other offering or publicity material relating to the Securities, in each case, in any country or
jurisdiction where action for that purpose is required. 

 (d)    JPMorgan warrants and agrees that: 

(i)    it has only communicated or caused to be communicated and will only communicate or cause to be communicated any
invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the “FSMA”)) received by it in connection with the issue or sale of any Securities in
circumstances in which Section 21(1) of the FSMA does not apply to the Company; and 
 (ii)    it has complied and
will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Securities in, from or otherwise involving the United Kingdom.Exhibit 10.1

 Exhibit 10.1 

FORM OF PREFERRED STOCK AGREEMENT 

ALTISOURCE ASSET MANAGEMENT CORPORATION 

The undersigned participant (the “Participant”) of the 2016 Employee Preferred Stock Plan (the “Plan”) of ALTISOURCE ASSET
MANAGEMENT CORPORATION (the “Company”), a copy of which is attached hereto as Exhibit A, hereby acknowledges receipt of              shares of Class
     Preferred Stock of the Company (“Preferred Stock”) issued pursuant to the Plan. As required under Section 7 of the Plan, the Participant hereby (i) agrees that such shares of Preferred Stock shall
be subject to, and shall be held by [him/her] in accordance with all of the applicable terms and provisions of, the Plan, and (ii) represents and warrants to the Company that [he/she] has acquired such shares of Preferred Stock for investment
for [his/her] own account, and (iii) in any event, agrees that [he/she] will not sell or otherwise dispose of said shares other than sales back to the Company upon termination of employment with the Company as required under the provisions of
Section 7.02 of the Plan. 
 The undersigned hereby executes this Preferred Stock Agreement this      day of
                    , 201    . 

 

	
	  

	[name of recipient]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00265-of-00352.parquet"}]]